🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Our investigational team has developed a technology to visualize the operat...
Status
Suspended
Location
Laser LabCorp
Start Date
2021-12-15
Trial ID
NCT04683120
Treatments Being Tested
The study aspires to provide outcomes on surgery, quality of life and time-...
Status
Recruiting
Location
Westmead Breast Cancer Institute
Start Date
2020-01-01
Trial ID
NCT06401304
In patients undergoing breast-conserving surgery and having positive sentin...
Status
Completed
Location
Peking university people's hospital
Start Date
2014-11-01
Trial ID
NCT03606616
Treatments Being Tested
Breast-conserving surgery (BCS) is the traditional surgical treatment for e...
Status
Unknown
Location
Multiple Locations
Start Date
2021-10-01
Trial ID
NCT05054777
Treatments Being Tested
Sentinel lymph node biopsy (SLNB) has become the standard procedure for sta...
Status
Terminated
Location
Institut Bergonie
Start Date
2018-05-29
Trial ID
NCT03630653
Treatments Being Tested
This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Status
Completed
Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Start Date
2022-07-05
Trial ID
NCT05415215
In this protocol we combine two available and reliable treatments - lumpect...
Status
Completed
Location
University of Arkansas For Medical Sciences
Start Date
2004-09
Trial ID
NCT00571987
Higher rates of complications and poorer cosmetic outcomes have been report...
Status
Completed
Location
Morgagni Pierantoni Hospital
Start Date
2007-06
Trial ID
NCT06119633
Treatments Being Tested
This is a phase I- II feasibility study for delivering partial breast irrad...
Status
Terminated
Location
University of Michigan
Start Date
2004-11
Trial ID
NCT00581529
Treatments Being Tested
Endocrine therapy (ET) is widely used to treat hormone receptor positive br...
Status
Recruiting
Location
University of California at Los Angeles
Start Date
2020-03-11
Trial ID
NCT04297020